Filing Details

Accession Number:
0001209191-20-042067
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-09 20:45:02
Reporting Period:
2020-07-07
Accepted Time:
2020-07-09 20:45:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296322 J Richard Benjamin C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94505
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-07 100,000 $4.72 141,763 No 4 M Direct
Common Stock Disposition 2020-07-07 100,000 $7.20 41,763 No 4 S Direct
Common Stock Acquisiton 2020-07-07 22,917 $4.33 64,680 No 4 M Direct
Common Stock Disposition 2020-07-07 22,917 $7.20 41,763 No 4 S Direct
Common Stock Acquisiton 2020-07-07 31,666 $4.32 73,429 No 4 M Direct
Common Stock Disposition 2020-07-07 31,666 $7.20 41,763 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2020-07-07 100,000 $0.00 100,000 $4.72
Common Stock Option (Right to Buy) Disposition 2020-07-07 22,917 $0.00 22,917 $4.33
Common Stock Option (Right to Buy) Disposition 2020-07-07 31,666 $0.00 31,666 $4.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,000 2025-08-31 No 4 M Direct
25,000 2027-02-28 No 4 M Direct
23,750 2028-02-28 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  2. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
  3. Not applicable.